Mylan, Lupin Prevail In Generic-Seasonique Patent Suit

Law360, New York (July 2, 2012, 6:07 PM EDT) -- Mylan Inc. and Lupin Ltd. scored a victory Friday in a Teva Women's Health Inc. lawsuit over efforts to market generic versions of Teva's oral contraceptive Seasonique, when the sole patent claim being asserted by Teva was deemed invalid.

U.S. District Judge Peter G. Sheridan issued a 47-page opinion that said the claim at issue was invalid and signed off on an order dismissing the case with prejudice. Mylan and Lupin previously stipulated that their abbreviated new drug applications for generic Seasonique would infringe that claim,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.